Trends of Adverse Events Following Immunization (AEFI) Reports of Human Papillomavirus Vaccine in the Valencian Community—Spain (2008–2018)

Trends of Adverse Events Following Immunization (AEFI) Reports of Human Papillomavirus Vaccine in the Valencian Community—Spain (2008–2018)

Vaccine safety surveillance is essential in vaccination programs. We accomplished a descriptive study of surveillance AEFI-reporting rate in human papillomavirus (HPV) vaccine administered in the Valencian Community, Spain. Data were obtained from Spanish Pharmacovigilance Adverse Reactions Data (FE...

Full description

Bibliographic Details
Main Authors:	Cecilia M. Egoavil, José Tuells, Juan José Carreras, Emilia Montagud, Eliseo Pastor-Villalba, Pablo Caballero, Andreu Nolasco
Format:	Article
Language:	English
Published:	MDPI AG 2020-03-01
Series:	Vaccines
Subjects:	adverse events following immunization (aefis) human papillomavirus vaccines spanish pharmacovigilance system vaccine safety postlicensure surveillance
Online Access:	https://www.mdpi.com/2076-393X/8/1/117

Similar Items

Using Population-Based Structures to Actively Monitor AEFIs during a Mass Immunization Campaign—A Case of Measles–Rubella and Polio Vaccines
by: Dan Kajungu, et al.
Published: (2021-11-01)

Farmacovigilancia de vacunas y su aplicación en Chile
by: Adiela Saldaña, et al.
Published: (2020-05-01)

Does This COVID-19 Pandemic Demand a Scale Up in AEFI Reporting in India?
by: Sadhvika Kanagat, et al.
Published: (2022-09-01)

Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine using the national adverse event following immunization surveillance system from Zhejiang province, 2018-2020
by: Yu Hu, et al.
Published: (2021-12-01)

Vaccine Safety International Monitoring
by: M. A. Darmostukova, et al.
Published: (2019-03-01)

A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study
by: Mohamed Serhan, et al.
Published: (2024-12-01)

Hazards of vaccinating the way out of Covid-19 pandemic: Study of adverse events following immunization (Aefi) in India
by: Priti Nandkishor Tiwari, et al.
Published: (2022-01-01)

Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization’s Reporting? A Pharmacovigilance Study in Southern Italy
by: Cristina Scavone, et al.
Published: (2018-09-01)

Real-world safety profile of the 9-valent human papillomavirus vaccine: A study in Zhejiang, China from 2019 to 2021
by: Fuxing Chen, et al.
Published: (2022-12-01)

Surveillance of Adverse Events Following Immunization (AEFI) after Third Dose Booster Vaccination with mRNA-Based Vaccine in Universitas Indonesia Hospital Health Personnel
by: Rakhmad Hidayat, et al.
Published: (2022-05-01)

NEUROLOGICAL ADVERSE EVENTS FOLLOWING IMMUNIZATION (AEFI) ON HEALTH WORKFORCE OF A SECONDARY REFERRAL HOSPITAL IN SOUTH SULAWESI WHO RECEIVED THE
by: Lutpyah L, et al.
Published: (2022-12-01)

Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system
by: Xuejiao Pan, et al.
Published: (2021-10-01)

Potential immediate hypersensitivity reactions following immunization in preschool aged children in Victoria, Australia
by: C.-M. Baxter, et al.
Published: (2018-08-01)

Non-specific effects of vaccinations in high-income settings: How to address the issue?
by: Alberto Donzelli, et al.
Published: (2018-12-01)

Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study
by: Alessia Zinzi, et al.
Published: (2023-02-01)

Safety of COVID-19 vaccines
by: B. K. Romanov
Published: (2022-12-01)

Understanding and experience of adverse event following immunization (AEFI) and its consequences among healthcare providers in Kebbi State, Nigeria: a qualitative study
by: Semeeh Akinwale Omoleke, et al.
Published: (2022-06-01)

Building confidence in COVID-19 vaccine rollout: the importance of responsible presentation and follow-on investigation of Adverse Events Following Immunization (AEFI) reports for elderly patients
by: Razmin Bari, et al.
Published: (2024-02-01)

Surveillance on the adverse events following immunization in Dazu District of Chongqing， 2016‒2020
by: WANG Qian, et al.
Published: (2022-04-01)

The papillomaviruses /
by: Garcea, Robert L., et al.
Published: (2007)

Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine
by: Lina S. Sy, et al.
Published: (2018-02-01)

Adverse Events Following Immunization with DTP Vaccine in Infants and Children in Kermanshah City: A Cohort Study
by: M Karami, et al.
Published: (2006-02-01)

SYSTEMATIC USE OF CAUSALITY ASSESSMENT IN AEFI SURVEILLANCE: A 2013-2016 PILOT STUDY IN PUGLIA
by: Pasquale Stefanizzi
Published: (2017-10-01)

A Retrospective Cross-Sectional Study Assessing Self-Reported Adverse Events following Immunization (AEFI) of the COVID-19 Vaccine in Bangladesh
by: Arifa Sultana, et al.
Published: (2021-09-01)

Real-Life Safety Profile of the 9-Valent HPV Vaccine Based on Data from the Puglia Region of Southern Italy
by: Antonio Di Lorenzo, et al.
Published: (2022-03-01)

Safety Profile of Recommended Vaccinations in Adolescents: Data from Surveillance of Adverse Events Following Immunization in Puglia (Italy), 2016–2020
by: Antonio Di Lorenzo, et al.
Published: (2021-11-01)

Safety profile of inactivated COVID-19 vaccine in indonesian adults
by: Hindra Irawan Satari, et al.
Published: (2023-08-01)

ANTIBODY IgG LEVELS AND ADVERSE EVENTS FOLLOWING IMMUNIZATION AFTER THIRD DOSE OF MODERNA VACCINE IN HEALTHWORKERS AFTER TWO DOSES OF SINOVAC VACCINE
by: Ade Tiur Rumondang, et al.
Published: (2023-05-01)

Evaluation of the adverse events following immunization surveillance system in Guruve district, Mashonaland Central 2017
by: Mutata Constantine, et al.
Published: (2018-11-01)

A field based evaluation of adverse events following MenAfriVac, vaccine delivered in a controlled temperature chain (CTC) approach in Benin
by: Christoph Steffen, et al.
Published: (2014-08-01)

Investigation of Adverse Events Experienced by Healthcare Workers following Immunization with Homologous or Heterologous COVID-19 Booster Vaccinations
by: Yunhua Wei, et al.
Published: (2022-11-01)

Comparative Study of AEFI of Hepatitis B Vaccine between Iran Ministry of Health CDC and VAERS Data during 2015 to 2017
by: Hamidreza Hozouri, et al.
Published: (2021-06-01)

A study to determine adverse event following immunization using COVISHIELD vaccine for prevention of COVID-19 infection in a field practice area of urban health center
by: Sarika P Patil, et al.
Published: (2022-06-01)

Safety profile of MenB-FHBp vaccine among adolescents: data from surveillance of Adverse Events Following Immunization in Puglia (Italy), 2018–2020
by: Pasquale Stefanizzi, et al.
Published: (2022-01-01)

Knowledge and Attitudes about the Flu Vaccine among Pregnant Women in the Valencian Community (Spain)
by: Noelia Rodríguez-Blanco, et al.
Published: (2019-08-01)

The eight-year long-term follow-up on the effectiveness of the quadrivalent human papillomavirus vaccine in Chinese women 20-45 years of age
by: Chao Zhao, et al.
Published: (2022-11-01)

Intussusception and Other Adverse Event Surveillance after Pilot Introduction of Rotavirus Vaccine in Nam Dinh and Thua Thien Hue Provinces—Vietnam, 2017–2021
by: Ly Khanh Thi Le, et al.
Published: (2024-02-01)

Discrepancies in the evaluation of the safety of the human papillomavirus vaccine
by: Jorge L Cervantes, et al.
Published: (2018-05-01)

Incidence of early adverse events following covishield (ChAdOx1 nCoV-19) vaccination: A prospective study
by: Gajanan D Velhal, et al.
Published: (2022-01-01)

Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up
by: Susanne K. Kjaer, et al.
Published: (2021-04-01)